Regeneron ’s REGN-COV2 is first antibody cocktail for COVID-19 to receive FDA emergency use authorization

Dear Investor, Please find attached a press release from our partner Regeneron:
Source: Roche Investor Update - Category: Pharmaceuticals Source Type: news